|
|||||
|
|
CHO cells knocked out for TSC2 display an improved productivity of antibodies under fed batch conditions |
|
| Authors: | Duncan McVey Michael Aronov Giovanni Rizzi Alexis Cowan Charo Scott John Megill Reb Russell Boaz Tirosh |
| Affiliation: | 1. Division of Global Manufacturing and Supply, Bristol Myers Squibb Company, Bloomsbury, New Jersey;2. Institute for Drug Research, The School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem 91120, Israel;3. Discovery Toxicology, Bristol Myers Squibb Company, Pennington, New Jersey;4. +972‐2‐6758730+972‐2‐6758741 |
| Abstract: | |
| Keywords: | mTOR CRISPR/Cas9 CHO cells productivity |
